Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
64.47B
Market cap64.47B
Price-Earnings ratio
24.60
Price-Earnings ratio24.60
Dividend yield
0.73%
Dividend yield0.73%
Average volume
1.14M
Average volume1.14M
High today
$337.92
High today$337.92
Low today
$329.15
Low today$329.15
Open price
$333.26
Open price$333.26
Volume
1.48M
Volume1.48M
52 Week high
$377.54
52 Week high$377.54
52 Week low
$244.82
52 Week low$244.82

Stock Snapshot

The current Cencora, Inc.(COR) stock price is $337.84, with a market capitalization of 64.47B. The stock trades at a price-to-earnings (P/E) ratio of 24.60 and offers a dividend yield of 0.73%.

On 2026-11-02, Cencora, Inc.(COR) stock moved within a range of $329.15 to $337.92. With shares now at $337.84, the stock is trading +2.6% above its intraday low and -0.0% below the session's peak.

Trading volume for Cencora, Inc.(COR) stock has reached 1.48M, versus its average volume of 1.14M.

The stock's 52-week range extends from a low of $244.82 to a high of $377.54.

The stock's 52-week range extends from a low of $244.82 to a high of $377.54.

COR News

Simply Wall St 2d
Is Cencora A Bargain As Oncology Expansion And Q4 Estimates Come Into Focus?

Cencora (COR) just drew fresh attention after analysts outlined expectations for its upcoming quarter, highlighting projected earnings of $4.55 per share on US$...

Zacks 3d
Cencora Gears Up to Report Q4 Results: How to Play the Stock?

Cencora, Inc. (COR Quick QuoteCOR - Free Report) is slated to report fourth-quarter fiscal 2026 results on Nov. 4, before market open. In the last report...

Cencora Gears Up to Report Q4 Results: How to Play the Stock?
Zacks 5d
Cencora to Acquire AON in $2.4B Deal to Expand Oncology Network

Cencora, Inc. (COR Quick QuoteCOR - Free Report) recently announced a definitive agreement to acquire American Oncology Network (“AON”), a physician-led n...

Cencora to Acquire AON in $2.4B Deal to Expand Oncology Network

Analyst ratings

61%

of 18 ratings
Buy
61.1%
Hold
38.9%
Sell
0%

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.